本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Alterity Therapeutics Limited

3.86
-0.1900-4.69%
成交量:3.30萬
成交額:12.80萬
市值:6,996.52萬
市盈率:-4.18
高:4.02
開:4.02
低:3.83
收:4.05
52周最高:5.89
52周最低:2.66
股本:1,812.57萬
流通股本:1,448.44萬
量比:1.39
換手率:0.23%
股息:- -
股息率:- -
每股收益(TTM):-0.9231
每股收益(LYR):-0.9231
淨資產收益率:-54.98%
總資產收益率:-34.08%
市淨率:2.30
市盈率(LYR):-4.18

資料載入中...

2020/07/06

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/03/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/27

非美公司披露報告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/17

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/15

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/23

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/11

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/21

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/20

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/25

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]